Pfizer (Germany) Today

PFE Stock  EUR 24.30  0.07  0.29%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Less than 9

 
High
 
Low
Low
Pfizer is trading at 24.30 as of the 17th of April 2024. This is a -0.29 percent down since the beginning of the trading day. The stock's lowest day price was 24.3. Pfizer has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Pfizer Inc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 18th of March 2024 and ending today, the 17th of April 2024. Click here to learn more.
Pfizer Inc. develops, manufactures, and sells healthcare products worldwide. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York. PFIZER INC operates under Drug Manufacturers - Major classification in Germany and is traded on Frankfurt Stock Exchange. The company has 5.62 B outstanding shares. More on Pfizer Inc
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Pfizer Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Pfizer's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Pfizer or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Chairman of the Board, CEOIan Read
Business ConcentrationDrug Manufacturers - Major, Healthcare (View all Sectors)
Pfizer Inc (PFE) is traded on Frankfurt Exchange in Germany and employs 83,000 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 212.98 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Pfizer's market, we take the total number of its shares issued and multiply it by Pfizer's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Pfizer Inc classifies itself under Healthcare sector and is part of Drug Manufacturers - Major industry. The entity has 5.62 B outstanding shares. Pfizer Inc has accumulated about 11.7 B in cash with 32.58 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.1.
Check Pfizer Probability Of Bankruptcy
Ownership Allocation
Pfizer owns a total of 5.62 Billion outstanding shares. The majority of Pfizer Inc outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Pfizer Inc to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Pfizer. Please pay attention to any change in the institutional holdings of Pfizer Inc as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Pfizer Ownership Details

Pfizer Stock Price Odds Analysis

In reference to a normal probability distribution, the odds of Pfizer jumping above the current price in 90 days from now is roughly 97.0%. The Pfizer Inc probability density function shows the probability of Pfizer stock to fall within a particular range of prices over 90 days. Assuming the 90 days horizon Pfizer has a beta of 0.4253 indicating as returns on the market go up, Pfizer average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Pfizer Inc will be expected to be much smaller as well. Additionally, pfizer Inc has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
  Odds Below 24.3HorizonTargetOdds Above 24.3
3.19%90 days
 24.30 
96.71%
Based on a normal probability distribution, the odds of Pfizer to move above the current price in 90 days from now is roughly 97.0 (This Pfizer Inc probability density function shows the probability of Pfizer Stock to fall within a particular range of prices over 90 days) .

Pfizer Inc Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Pfizer market risk premium is the additional return an investor will receive from holding Pfizer long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Pfizer. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Pfizer's alpha and beta are two of the key measurements used to evaluate Pfizer's performance over the market, the standard measures of volatility play an important role as well.

Pfizer Stock Against Markets

Picking the right benchmark for Pfizer stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Pfizer stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Pfizer is critical whether you are bullish or bearish towards Pfizer Inc at a given time. Please also check how Pfizer's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Pfizer without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Price Exposure Probability Now

   

Price Exposure Probability

Analyze equity upside and downside potential for a given time horizon across multiple markets
All  Next Launch Module

Pfizer Corporate Directors

Pfizer corporate directors refer to members of a Pfizer board of directors. The board of directors generally takes responsibility for the Pfizer's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Pfizer's board members must vote for the resolution. The Pfizer board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Helen HobbsIndependent DirectorProfile
Shantanu NarayenDirectorProfile
James SmithDirectorProfile
Dennis AusielloIndependent DirectorProfile

How to buy Pfizer Stock?

Before investing in Pfizer, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Pfizer. To buy Pfizer stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Pfizer. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Pfizer stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Pfizer Inc stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Pfizer Inc stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Pfizer Inc, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Pfizer Stock please use our How to Invest in Pfizer guide.

Already Invested in Pfizer Inc?

The danger of trading Pfizer Inc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Pfizer is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Pfizer. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Pfizer Inc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Pfizer Inc is a strong investment it is important to analyze Pfizer's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pfizer's future performance. For an informed investment choice regarding Pfizer Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pfizer Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Complementary Tools for Pfizer Stock analysis

When running Pfizer's price analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Please note, there is a significant difference between Pfizer's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pfizer is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pfizer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.